Free Trial

Extendicare (TSE:EXE) Reaches New 12-Month High After Dividend Announcement

Extendicare logo with Medical background
Remove Ads

Shares of Extendicare Inc. (TSE:EXE - Get Free Report) hit a new 52-week high during trading on Monday following a dividend announcement from the company. The stock traded as high as C$12.90 and last traded at C$12.88, with a volume of 81017 shares trading hands. The stock had previously closed at C$12.41.

The newly announced dividend which will be paid on Monday, March 17th. Investors of record on Monday, March 17th will be given a $0.04 dividend. This represents a $0.48 annualized dividend and a yield of 3.69%. The ex-dividend date is Friday, February 28th. Extendicare's dividend payout ratio (DPR) is presently 61.20%.

Analyst Upgrades and Downgrades

EXE has been the topic of a number of recent research reports. Royal Bank of Canada increased their price objective on Extendicare from C$9.50 to C$11.00 and gave the company a "sector perform" rating in a research report on Thursday, November 28th. BMO Capital Markets raised their price target on Extendicare from C$11.00 to C$13.50 in a report on Monday. TD Securities upped their target price on shares of Extendicare from C$10.50 to C$13.00 and gave the company a "hold" rating in a research report on Monday. Finally, Cormark upgraded shares of Extendicare to a "moderate buy" rating in a research report on Wednesday, February 19th. Three equities research analysts have rated the stock with a hold rating and one has given a buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of "Hold" and an average target price of C$11.50.

Read Our Latest Report on EXE

Extendicare Trading Down 0.5 %

The company has a market capitalization of C$1.09 billion, a P/E ratio of 16.59 and a beta of 1.26. The business has a 50 day moving average price of C$10.84 and a 200 day moving average price of C$9.86. The company has a current ratio of 0.62, a quick ratio of 0.98 and a debt-to-equity ratio of 283.02.

Remove Ads

About Extendicare

(Get Free Report)

Extendicare Inc, operating solely in Canada, is the largest private-sector owner and operator of long-term care (LTC") homes and one of the largest private-sector providers of publicly funded home health care services.

Featured Stories

Should You Invest $1,000 in Extendicare Right Now?

Before you consider Extendicare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Extendicare wasn't on the list.

While Extendicare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

Quantum Stocks Are Heating Up Again — 7 to Watch Now
Stock Market on Sale – Buy Now Before the Next Big Surge
Google’s $32B Move: 3 Cybersecurity Stocks to Watch

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads